Jean‐Baptiste Arnoux

2.8k total citations
63 papers, 1.2k citations indexed

About

Jean‐Baptiste Arnoux is a scholar working on Clinical Biochemistry, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Jean‐Baptiste Arnoux has authored 63 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Clinical Biochemistry, 26 papers in Molecular Biology and 15 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Jean‐Baptiste Arnoux's work include Metabolism and Genetic Disorders (36 papers), Neonatal Health and Biochemistry (15 papers) and Hyperglycemia and glycemic control in critically ill and hospitalized patients (15 papers). Jean‐Baptiste Arnoux is often cited by papers focused on Metabolism and Genetic Disorders (36 papers), Neonatal Health and Biochemistry (15 papers) and Hyperglycemia and glycemic control in critically ill and hospitalized patients (15 papers). Jean‐Baptiste Arnoux collaborates with scholars based in France, United Kingdom and United States. Jean‐Baptiste Arnoux's co-authors include Pascale de Lonlay, Vassili Valayannopoulos, Cécile Saint‐Martin, Christine Bellanné‐Chantelot, Anaïs Brassier, Virginie Verkarre, Chris Ottolenghi, Claire Nihoul‐Feketé, Jacques Rahier and Jean‐Jacques Robert and has published in prestigious journals such as Nature Communications, The Journal of Clinical Endocrinology & Metabolism and Diabetes Care.

In The Last Decade

Jean‐Baptiste Arnoux

60 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jean‐Baptiste Arnoux France	19	507	419	360	313	238	63	1.2k
Jean-Marie Saudubray France	14	333 0.7×	383 0.9×	397 1.1×	210 0.7×	111 0.5×	15	952
F Poggi-Travert France	8	470 0.9×	284 0.7×	307 0.9×	261 0.8×	90 0.4×	13	881
Arianna Maiorana Italy	17	215 0.4×	226 0.5×	130 0.4×	123 0.4×	108 0.5×	52	839
Leighton R. James United States	19	166 0.3×	472 1.1×	136 0.4×	103 0.3×	92 0.4×	38	961
Sandrine Vuillaumier‐Barrot France	21	129 0.3×	858 2.0×	102 0.3×	133 0.4×	195 0.8×	54	1.3k
Florence Habarou France	16	96 0.2×	372 0.9×	250 0.7×	134 0.4×	54 0.2×	23	727
Elisabetta Pasquini Italy	23	120 0.2×	589 1.4×	698 1.9×	80 0.3×	158 0.7×	59	1.4k
Daniel Walcher Germany	19	574 1.1×	664 1.6×	119 0.3×	411 1.3×	219 0.9×	44	1.5k
Seung Ho Hong South Korea	17	204 0.4×	236 0.6×	64 0.2×	242 0.8×	74 0.3×	40	860
Minoru Okubo Japan	22	622 1.2×	277 0.7×	60 0.2×	697 2.2×	539 2.3×	82	1.5k

Countries citing papers authored by Jean‐Baptiste Arnoux

Since Specialization

Citations

This map shows the geographic impact of Jean‐Baptiste Arnoux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean‐Baptiste Arnoux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean‐Baptiste Arnoux more than expected).

Fields of papers citing papers by Jean‐Baptiste Arnoux

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean‐Baptiste Arnoux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean‐Baptiste Arnoux. The network helps show where Jean‐Baptiste Arnoux may publish in the future.

Co-authorship network of co-authors of Jean‐Baptiste Arnoux

This figure shows the co-authorship network connecting the top 25 collaborators of Jean‐Baptiste Arnoux. A scholar is included among the top collaborators of Jean‐Baptiste Arnoux based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean‐Baptiste Arnoux. Jean‐Baptiste Arnoux is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Löfvendahl, Sofia, Mattias Rudebeck, Peter Lindgren, et al.. (2024). Societal costs and quality of life associated with arginase 1 deficiency in a European setting – a multinational, cross-sectional survey. Journal of Medical Economics. 27(1). 1146–1156. 3 indexed citations

Arnoux, Jean‐Baptiste, Claire Douillard, F. Maillot, et al.. (2024). Health economic impact of patients with phenylketonuria (PKU) in France – A nationwide study of health insurance claims data. Molecular Genetics and Metabolism Reports. 41. 101134–101134. 1 indexed citations

Löfvendahl, Sofia, Peter Lindgren, Karolina M. Stępień, et al.. (2024). Disease burden among patients with Arginase 1 deficiency and their caregivers: A multinational, cross‐sectional survey. JIMD Reports. 65(6). 450–460. 1 indexed citations

Busiah, Kanetee, Célina Roda, Anaïs Brassier, et al.. (2024). Pubertal origin of growth retardation in inborn errors of protein metabolism: A longitudinal cohort study. Molecular Genetics and Metabolism. 141(3). 108123–108123. 1 indexed citations

Feillet, François, Jean‐Baptiste Arnoux, Alberto Burlina, et al.. (2024). Long‐term safety of sapropterin in paediatric and adult individuals with phenylalanine hydroxylase deficiency: Final results of the Kuvan® Adult Maternal Paediatric European Registry multinational observational study. Journal of Inherited Metabolic Disease. 48(1). e12796–e12796. 1 indexed citations

Roux, Charles‐Joris, Rémi Barrois, Apolline Imbard, et al.. (2024). Vitamin deficiencies in children: Lessons from clinical and neuroimaging findings. European Journal of Paediatric Neurology. 50. 6–15. 3 indexed citations

Douillard, Claire, Jean‐Baptiste Arnoux, S. Bouée, et al.. (2023). Health status and comorbidities of adult patients with late-diagnosed phenylketonuria (PKU) born before the newborn screening in France – A nationwide study of health insurance claims data. Molecular Genetics and Metabolism. 140(3). 107704–107704. 5 indexed citations

Imbard, Apolline, Juliette Bouchereau, Jean‐Baptiste Arnoux, et al.. (2023). Citrulline in the management of patients with urea cycle disorders. Orphanet Journal of Rare Diseases. 18(1). 207–207. 6 indexed citations

Pontoizeau, Clément, Marion Benoist, Pasqualina Colella, et al.. (2023). Successful treatment of severe MSUD in Bckdhb^−/− mice with neonatal AAV gene therapy. Journal of Inherited Metabolic Disease. 47(1). 41–49. 4 indexed citations

10.

Labarthe, François, Caroline Moreau, Jean‐Baptiste Arnoux, et al.. (2023). Newborn Screening of Primary Carnitine Deficiency: An Overview of Worldwide Practices and Pitfalls to Define an Algorithm before Expansion of Newborn Screening in France. International Journal of Neonatal Screening. 9(1). 6–6. 9 indexed citations

11.

Pontoizeau, Clément, Pasqualina Colella, M Girard, et al.. (2022). Neonatal gene therapy achieves sustained disease rescue of maple syrup urine disease in mice. Nature Communications. 13(1). 3278–3278. 14 indexed citations

12.

Mention, Karine, Manuel Schiff, Jean‐Baptiste Arnoux, et al.. (2022). Intravenous administration of a branched-chain amino-acid-free solution in children and adults with acute decompensation of maple syrup urine disease: a prospective multicentre observational study. Orphanet Journal of Rare Diseases. 17(1). 202–202. 2 indexed citations

13.

Grimaud, Marion, Pascale de Lonlay, Laurent Dupic, et al.. (2016). High glucose intake and glycaemic level in critically ill neonates with inherited metabolic disorders of intoxication. European Journal of Pediatrics. 175(6). 849–858. 1 indexed citations

14.

Hamel, Yamina, François‐Xavier Mauvais, Hang‐Phuong Pham, et al.. (2016). A unique CD8+ T lymphocyte signature in pediatric type 1 diabetes. Journal of Autoimmunity. 73. 54–63. 10 indexed citations

15.

Jones, Simon, Dominique Plantaz, Roshni Vara, et al.. (2015). Effect of sebelipase alfa on survival and liver function in infants with rapidly progressive lysosomal acid lipase deficiency. Molecular Genetics and Metabolism. 114(2). S59–S59. 6 indexed citations

16.

Sang, Kim‐Hanh Le Quan, Jean‐Baptiste Arnoux, Asmaa Mamoune, et al.. (2011). Successful treatment of congenital hyperinsulinism with long-acting release octreotide. European Journal of Endocrinology. 166(2). 333–339. 60 indexed citations

17.

Lonlay, Pascale de, Vassili Valayannopoulos, Jean‐Baptiste Arnoux, et al.. (2010). Démarche diagnostique et thérapeutique d’une maladie métabolique en anesthésie-réanimation. Archives de Pédiatrie. 17(6). 947–948. 1 indexed citations

18.

Bellanné‐Chantelot, Christine, Cécile Saint‐Martin, M.J. Santiago Ribeiro, et al.. (2010). ABCC8 and KCNJ11 molecular spectrum of 109 patients with diazoxide-unresponsive congenital hyperinsulinism. Journal of Medical Genetics. 47(11). 752–759. 90 indexed citations

19.

Saint‐Martin, Cécile, Jean‐Baptiste Arnoux, Pascale de Lonlay, & Christine Bellanné‐Chantelot. (2010). KATP channel mutations in congenital hyperinsulinism. Seminars in Pediatric Surgery. 20(1). 18–22. 25 indexed citations

20.

Arnoux, Jean‐Baptiste, Nathalie Boddaert, Vassili Valayannopoulos, et al.. (2008). Risk assessment of acute vascular events in congenital disorder of glycosylation type Ia. Molecular Genetics and Metabolism. 93(4). 444–449. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact